Friday, March 31, 2023 | Back issues
Courthouse News Service Courthouse News Service

Pharmaceutical Merger

WILMINGTON, Del. - Directors are selling Cadence Pharmaceuticals too cheaply through an unfair process to Mallinckrodt, for $14 per share or $1.3 billion, a class action claims in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.